GlobeNewswire (Tue, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (Wed, 3:30PM)
-
GlobeNewswire (May 13, 2013)
-
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 16, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Feb 20, 2013)
-
GlobeNewswire (Feb 6, 2013)
-
GlobeNewswire (Jan 7, 2013)
-
GlobeNewswire (Jan 3, 2013)
-
GlobeNewswire (Nov 27, 2012)
-
-
-
IPO Preview: ChemoCentryxIPOdesktop • Tue, Feb 7, 2012
-
GlobeNewswire (Tue, 8:00AM)
-
GlobeNewswire (Wed, 3:30PM)
-
GlobeNewswire (May 13, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 16, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Feb 20, 2013)
-
GlobeNewswire (Feb 6, 2013)
-
GlobeNewswire (Jan 7, 2013)
-
GlobeNewswire (Jan 3, 2013)
-
GlobeNewswire (Nov 27, 2012)
-
GlobeNewswire (Nov 13, 2012)
-
GlobeNewswire (Nov 5, 2012)
-
GlobeNewswire (Aug 30, 2012)
CCXI vs. ETF Alternatives
Company Description
ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. Our approach has been to target the chemokine system, a network of molecules including chemokine... More
